RALPH BATES PANCREATIC CANCER RESEARCH FUND
To promote, carry out or participate in research into pancreatic cancer and associated diseases by way of grant, loans, remuneration etc to hospitals, universities, colleges and similar bodies engaged in research. To provide relief and comfort to pancreatic cancer sufferers.
Objects
A)PROMOTION OF RESEARCH INTO PANCREATIC CANCER AND ASSOCIATED DISEASES.B)CARRYING OUT OF SUCH RESEARCH.C)PROVISION OF RELIEF FOR PANCREATIC CANCER SUFFERERS.D)ESTABLISHMENT OF FELLOWSHIPS OR SCHOLARSHIPS FOR PERSONS ENGAGED IN SUCH RESEARCH OR TREATMENT.
Financial health, per its FY2025 accounts
The accounts state that the charity operates with unrestricted funds in a deficit position of minus £4,276, having incurred a surplus of income over expenditure of £19,983 for the year. The independent examiner notes that while net worth is in deficit, cash flow projections and contractual agreements provide confidence in future funding. The trustees confirm there are no material uncertainties regarding the charity's ability to continue in operational existence.
What the accounts disclose
“The Trustees attempt to retain income and reserves to enable the funding known and potential expenditure of future research into pancreatic cancer and associated diseases, disabilities and conditions.” — page 5
Policies the charity declares
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Investing charity funds policy and procedures
- Trustee expenses policy and procedures
Trustees
- VIRGINIA MARY BATESchair
- Dr JOHN PAUL GLEES MD FRCR
- LESLIE RONALD BIGGS
- Michael Bridge FCA
- Nigel Patrick Baly
- SIR PETER BLAKE
- Sharon Sullivan
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £31k | £11k |
| 31/03/2024 | £91k | £216k |
| 31/03/2023 | £70k | £5k |
| 31/03/2022 | £27k | £2k |
| 31/03/2021 | £11k | £2k |
Common questions
Is RALPH BATES PANCREATIC CANCER RESEARCH FUND financially healthy?
Per its FY2025 accounts: The accounts state that the charity operates with unrestricted funds in a deficit position of minus £4,276, having incurred a surplus of income over expenditure of £19,983 for the year. The independent examiner notes that while net worth is in deficit, cash flow projections and contractual agreements provide confidence in future funding. The trustees confirm there are no material uncertainties regarding the charity's ability to continue in operational existence. Its FY2025 accounts were independently examined.